Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Insulin-Like Growth Factor I, Resistance To × dalotuzumab × 1 year × Clear all

Sponsor

Interventions

tislelizumab 1 teprotumumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡